The Role of Obsessive-Compulsive Factors in the Treatment of Binge-Eating Disorders: A Post-Hoc Analysis of a Double-Blind, Placebo-Controlled Trial of Dasotraline

被引：0
|
作者：
Loebel, Antony [1 ]
Goldman, Robert [1 ]
Citrome, Leslie [1 ]
Siu, Cynthia [1 ]
Tsai, Joyce [1 ]
Kent, Justine [1 ]
机构：
[1] Sunovion Pharmaceut Inc, Ft Lee, NJ USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2019年 / 44卷 / SUPPL 1期
关键词：
Binge Eating Disorder; Obsessive Compulsive Disorder; Dasotraline;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
M68
引用
收藏
页码：112 / 113
页数：2
相关论文
共 50 条
  • [31] A double-blind, placebo-controlled trial of the effect of fluoxetine on dietary intake in overweight women with and without binge-eating disorder
    Greeno, CG
    Wing, RR
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1996, 64 (03): : 267 - 273
  • [32] Tolcapone in Obsessive Compulsive Disorder: A Randomized Double-Blind Placebo-Controlled Crossover Trial
    Grant, Jon
    Chamberlain, Samuel
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 312 - 313
  • [33] Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder
    Costa, Daniel L. C.
    Diniz, Juliana B.
    Requena, Guaraci
    Joaquim, Marines A.
    Pittenger, Christopher
    Bloch, Michael H.
    Miguel, Euripedes C.
    Shavitt, Roseli G.
    JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78 (07) : E766 - +
  • [34] A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder
    Arnold, LM
    McElroy, SL
    Hudson, JI
    Welge, JA
    Bennett, AJ
    Keck, PE
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (11) : 1028 - 1033
  • [35] Atomoxetine in the treatment of binge-eating disorder: A randomized placebo-controlled trial
    McElroy, Susan L.
    Guerdjikova, Anna
    Kotwal, Renu
    Welge, Jeffrey A.
    Nelson, Erik B.
    Lake, Kathleen A.
    Keck, Paul E., Jr.
    Hudson, James I.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (03) : 390 - 398
  • [36] Efficacy and Safety of Dasotraline in Adults With Binge-Eating Disorder: A Randomized, Double-Blind, Fixed-Dose Trial
    Goldman, Robert
    Hudson, James
    McElroy, Susan
    Grilo, Carlos
    Tsai, Joyce
    Deng, Ling
    Kent, Justine
    Loebel, Antony
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S108 - S108
  • [37] Reboxetine Combination Therapy With Fluoxetine in Moderate to Severe Obsessive-Compulsive Disorder: A Placebo-Controlled, Double-Blind, Randomized Trial
    Tilaki, Erfaneh Hajian
    Hasanzadeh, Alireza
    Shalbafan, Mohammadreza
    Moghaddam, Hossein Sanjari
    Shamabadi, Ahmad
    Boroon, Mahsa
    Akhondzadeh, Shahin
    CLINICAL NEUROPHARMACOLOGY, 2023, 46 (05) : 175 - 180
  • [38] Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial
    Grilo, Carlos M.
    Lydecker, Janet A.
    Fineberg, Sarah K.
    Moreno, Jorge O.
    Ivezaj, Valentina
    Gueorguieva, Ralitza
    AMERICAN JOURNAL OF PSYCHIATRY, 2022, 179 (12): : 927 - 937
  • [39] Naproxen adjunct to fluoxetine for moderate-to-severe obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial
    Shamabadi, Ahmad
    Motavalian, Zahra
    Farahmand, Yalda
    Farahmand, Kimia
    Arabzadeh Bahri, Razman
    Askari, Sanaz
    Ansari, Sahar
    Fallahzadeh, Mohammadali
    Shalbafan, Mohammdreza
    Akhondzadeh, Shahin
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2024, 78 (12) : 810 - 817
  • [40] In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)
    Mohammad Haghighi
    Leila Jahangard
    Hamid Mohammad-Beigi
    Hafez Bajoghli
    Hassan Hafezian
    Alireza Rahimi
    Hamid Afshar
    Edith Holsboer-Trachsler
    Serge Brand
    Psychopharmacology, 2013, 228 : 633 - 640
12345